A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...

A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...

Atomic-scale imperfections in graphene transistors generate unique wireless fingerprints that cannot be copied or predicted, ...

Phase 1 results confirm investigational drug-candidate G1090N has a favorable safety and tolerability profile, supporting further clinical evaluationCompelling anti-inflammatory activity of G1090N was ...

Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion ...

Neuroplasticity is the brain's ability to reorganize its structure, functions, and connections in response to experience, injury, or disease. It allows the brain to change and adapt, for example, by ...

The hair follicle is a highly dynamic mini-organ that undergoes cyclic phases of growth, regression, and rest. The anagen ...

Company Continues Market Education on Microbiome-Based Memory Function and Mental Clarity Following September Launch; New ...

Impressively, the unit registered the lowest frequency loss of any chip to date. Specifically, the engineers noted that the new chip was 15x more stable and 100x more efficient in terms of microwave ...

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

Kyocera Corporation (President: Hideo Tanimoto; “Kyocera”)(TOKYO: 6971) announced that it has developed a new meta-lens that ...